Health Care & Life Sciences

WellPoint CFO says insurance 'mega-mergers' unlikely

February 9, 2010
Bloomberg News
WellPoint Inc. chief financial officer Wayne DeVeydt said President Obama's Federal Trade Commission is unlikely to approve mergers among the biggest insurers.
More

Lilly awards pay increases to top executives

February 8, 2010
Peter Schnitzler, J.K. Wall
Eli Lilly and Co. CEO John Lechleiter's total compensation increased $4.1 million in 2009.
More

Cardinal Health laying off 49 at local warehouse

February 8, 2010
 IBJ Staff
Cardinal Health notified the state on Feb. 3 that it laid off 37 workers at the end of January and plans to lay off 12 more effective April 3.
More

WellPoint: More employers involved in provider talksRestricted Content

February 6, 2010
J.K. Wall
Employer activism is on the rise when it comes to keeping hospitals honest in their negotiations with health insurers. Executives at Indianapolis-based WellPoint say more employers are airing their displeasure when hospital systems ask for double-digit reimbursement increases.
More

Health care venture capital swoons in Indy, holds steady statewide

February 6, 2010
 IBJ Staff
The uncertainty of health care reform and a bad economy curtailed venture capital flow in 2009.
More

Mississippi settles Zyprexa suit against Lilly for over $18M

February 4, 2010
Associated Press
Mississippi will receive $18.5 million from Indianapolis-based drugmaker Eli Lilly and Co. as part of a settlement over claims the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat.
More

Hill-Rom profit up 40 percent

February 4, 2010
J.K. Wall
Batesville maker of hospital equipment meets analysts' expectations, then raises full-year profit forecast.
More

UPDATE: Glasscock retirement marks WellPoint's maturation

February 3, 2010
J.K. Wall
Larry Glasscock will step down March 1 as WellPoint CEO Angela Braly takes over leadership of the company's board. She replaced Glasscock as CEO on June 1, 2007.
More

Chairman Glasscock retiring from WellPoint board

February 3, 2010
 IBJ Staff
Larry Glasscock will retire as chairman of WellPoint Inc.'s board, the Indianapolis-based health insurer said early Wednesday. Company CEO Angela Braly will assume the position March 1.
More

Health firms still attracting venture capital

February 3, 2010
J.K. Wall
The uncertainty of health care reform and a bad economy curtailed venture capital flow in 2009. That trend hit Indianapolis, but the rest of the state actually saw an increase.
More

Q&A: Dr. Kristine Courtney

February 3, 2010
J.K. Wall
Dr. Kristine Courtney, Eli Lilly and Co.’s senior director of corporate health services, describes how and why the company spent two years making its clinics some of the first to electronically swap patient records with a local hospital database.
More

Dow AgroSciences profit falls despite revenue increase

February 2, 2010
 IBJ Staff
Indianapolis-based Dow AgroSciences said Tuesday it posted a profit of $69 million in the fourth quarter, down 19 percent from the prior year because of increased research and development spending and higher administrative expenses. Revenue was up 17 percent.
More

Enzon Pharmaceuticals sells Indy drug plant; 100 local jobs safe

February 1, 2010
New Jersey-based Enzon Pharmaceuticals Inc. has sold its Indianapolis plant that manufactures specialty drugs in a deal that could top $300 million. The buyer says that the operations, which employ about 100, will remain in the city.
More

St. Vincent to buy Care Group, city's largest cardiology practice

January 30, 2010
J.K. Wall
St. Vincent Health is near an agreement to take over The Care Group LLC, the city's largest independent physician practice and largest cardiology group in the nation.
More

Federal rule tied to electronic medical records panned

January 30, 2010
J.K. Wall
The government has erected a high fence around a pot of $27 billion available to doctors and hospitals that successfully computerize their patient records by next year, sparking complaints.
More

City of Greenwood might fund launch of insulin makerRestricted Content

January 30, 2010
Kathleen McLaughlin
Greenwood-based Zimmerman Biotechnologies LLC hopes to become the first company in the United States to make generic insulin, a long-awaited development in diabetes treatment. The Greenwood Common Council on Feb. 1 will consider an $8.4 million deal that would finance construction of an insulin factory, as well as help Zimmerman with FDA-approval and equipment expenses.
More

Health care reform will go on regardless of federal government

January 30, 2010
 IBJ Staff
Massachusetts’ election of a Republican senator has put health reform legislation on life support. But for the health care industry, reform is a reality that isn’t going to die.
More

Lilly's profits fall, miss analyst expectations

January 28, 2010
J.K. Wall
The Indianapolis-based drugmaker says a weaker dollar depressed earnings in the fourth quarter compared with a year ago.
More

Express Scripts to add 182 pharmacy jobs by 2012

January 27, 2010
 IBJ Staff
Drug distribution firm that acquired former WellPoint subsidiary plans to consolidate specialty pharmacy work at local airport facility.
More

Health care reform dead; long live reform

January 27, 2010
J.K. Wall
Massachusetts’ election of a Republican senator has put health reform legislation on life support. But for the health care industry, reform is a reality that isn’t going to die.
More

Lilly looks to autoimmune drugs

January 27, 2010
J.K. Wall
Two local researchers show why Eli Lilly and Co. and its peers are interested in developing medicines to treat automimmune diseases: The costs of treating them are growing twice as fast as the prescription drug market.
More

Two companies set to make major local expansions

January 27, 2010
Express Scripts Inc. on the west side of Indianapolis and Zipp Speed Weaponry in Speedway are scheduled Wednesday afternoon to announce the creation of hundreds of new jobs.
More

WellPoint beats expectations, lowers '10 profit forecast

January 27, 2010
J.K. Wall
The Indianapolis-based health insurer earned $6.09 per share in 2009, excluding extraordinary items; it expects a $6-per-share profit in 2010.
More

Lilly shares get boost from OK of rival's drug

January 26, 2010
 IBJ Staff and Bloomberg News
Shares of Lilly and partner Amylin rose on hopes that their new version of Byetta will be approved following U.S. regulators' clearance of a similar drug.
More

Indianapolis hospitals extending reach statewide

January 23, 2010
J.K. Wall
St. Vincent Health's agreement to lease the county hospital in Salem for five years is the latest in a string of deals by Indianapolis hospital systems seeking a statewide presence.
More
Page  << 71 72 73 74 75 76 77 78 79 80 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT